These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 20628373)

  • 1. Stromal cells' B7-1 is a key stimulatory molecule for interleukin-10 production by HOZOT, a multifunctional regulatory T-cell line.
    Otani T; Tsuji-Takayama K; Okochi A; Yamamoto M; Takeuchi M; Yamasaki F; Nakamura S; Kibata M
    Immunol Cell Biol; 2011 Feb; 89(2):246-54. PubMed ID: 20628373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HOZOTs, novel human regulatory T-cell lines, exhibit helper or suppressor activities depending on dendritic cell or anti-CD3 stimulation.
    Sugimoto A; Suzuki M; Otani T; Okochi A; Takeuchi M; Yamasaki F; Nakamura S; Kibata M
    Exp Hematol; 2009 Dec; 37(12):1454-63. PubMed ID: 19819295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of programmed death 1 ligands by murine T cells and APC.
    Yamazaki T; Akiba H; Iwai H; Matsuda H; Aoki M; Tanno Y; Shin T; Tsuchiya H; Pardoll DM; Okumura K; Azuma M; Yagita H
    J Immunol; 2002 Nov; 169(10):5538-45. PubMed ID: 12421930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced suppression of polyclonal CD8
    Mu C; Zhang X; Wang L; Xu A; Ahmed KA; Pang X; Chibbar R; Freywald A; Huang J; Zhu Y; Xiang J
    J Leukoc Biol; 2017 May; 101(5):1221-1231. PubMed ID: 28096300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B7-1/2, but not PD-L1/2 molecules, are required on IL-10-treated tolerogenic DC and DC-derived exosomes for in vivo function.
    Ruffner MA; Kim SH; Bianco NR; Francisco LM; Sharpe AH; Robbins PD
    Eur J Immunol; 2009 Nov; 39(11):3084-90. PubMed ID: 19757438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Marked induction of CD4+CD8+ T cells with multifunctional properties by coculturing CD2+ cells with xenogeneic stromal cells.
    Otani T; Toraya T; Sugimoto A; Okochi A; Suzuki M; Takeuchi M; Yamasaki F; Nakamura S; Kibata M
    J Immunol Methods; 2011 Sep; 372(1-2):78-88. PubMed ID: 21767541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-2 activation of STAT5 enhances production of IL-10 from human cytotoxic regulatory T cells, HOZOT.
    Tsuji-Takayama K; Suzuki M; Yamamoto M; Harashima A; Okochi A; Otani T; Inoue T; Sugimoto A; Motoda R; Yamasaki F; Nakamura S; Kibata M
    Exp Hematol; 2008 Feb; 36(2):181-92. PubMed ID: 18023521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells.
    Tseng SY; Otsuji M; Gorski K; Huang X; Slansky JE; Pai SI; Shalabi A; Shin T; Pardoll DM; Tsuchiya H
    J Exp Med; 2001 Apr; 193(7):839-46. PubMed ID: 11283156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-8 and RANTES are signature cytokines made by HOZOT, a new type of regulatory T cells.
    Harashima A; Toraya T; Okochi A; Yamamoto M; Suzuki M; Otani T; Inoue T; Tsuji-Takayama K; Sugimoto A; Takeuchi M; Yamasaki F; Nakamura S; Kibata M
    Mol Immunol; 2009 Oct; 46(16):3310-9. PubMed ID: 19699525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-2-independent generation of FOXP3(+)CD4(+)CD8(+)CD25(+) cytotoxic regulatory T cell lines from human umbilical cord blood.
    Nakamura S; Suzuki M; Sugimoto A; Tsuji-Takayama K; Yamamoto M; Otani T; Inoue T; Harashima A; Okochi A; Motoda R; Yamasaki F; Orita K; Kibata M
    Exp Hematol; 2007 Feb; 35(2):287-96. PubMed ID: 17258077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Importance of CD80/CD86-CD28 interactions in the recognition of target cells by CD8+CD122+ regulatory T cells.
    Shi Z; Rifa'i M; Lee YH; Shiku H; Isobe K; Suzuki H
    Immunology; 2008 May; 124(1):121-8. PubMed ID: 18205792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel mechanisms of suppressor activity exhibited by cytotoxic regulatory T cell lines, HOZOT.
    Suzuki M; Sugimoto A; Harashima A; Otani T; Yamamoto M; Nakamura S; Yamasaki F; Nishiyama M; Okazaki Y; Kibata M
    Exp Hematol; 2009 Jan; 37(1):92-100. PubMed ID: 19013006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. UVR-induced regulatory T cells switch antigen-presenting cells from a stimulatory to a regulatory phenotype.
    Schwarz A; Schwarz T
    J Invest Dermatol; 2010 Jul; 130(7):1914-21. PubMed ID: 20336084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maturation of neonatal human CD4 T cells: III. Role of B7 co-stimulation at priming.
    Yang LP; Demeure CE; Byun DG; Vezzio N; Delespesse G
    Int Immunol; 1995 Dec; 7(12):1987-93. PubMed ID: 8746568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dendritic type, accessory cells within the mammalian thymic microenvironment. Antigen presentation in the dendritic neuro-endocrine-immune cellular network.
    Bodey B; Bodey B; Kaiser HE
    In Vivo; 1997; 11(4):351-70. PubMed ID: 9292303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human decidual stromal cells suppress cytokine secretion by allogenic CD4+ T cells via PD-1 ligand interactions.
    Nagamatsu T; Schust DJ; Sugimoto J; Barrier BF
    Hum Reprod; 2009 Dec; 24(12):3160-71. PubMed ID: 19729380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutting edge: induction of B7-H4 on APCs through IL-10: novel suppressive mode for regulatory T cells.
    Kryczek I; Wei S; Zou L; Zhu G; Mottram P; Xu H; Chen L; Zou W
    J Immunol; 2006 Jul; 177(1):40-4. PubMed ID: 16785496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-linking the B7 family molecule B7-DC directly activates immune functions of dendritic cells.
    Nguyen LT; Radhakrishnan S; Ciric B; Tamada K; Shin T; Pardoll DM; Chen L; Rodriguez M; Pease LR
    J Exp Med; 2002 Nov; 196(10):1393-8. PubMed ID: 12438431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function.
    Filaci G; Fravega M; Negrini S; Procopio F; Fenoglio D; Rizzi M; Brenci S; Contini P; Olive D; Ghio M; Setti M; Accolla RS; Puppo F; Indiveri F
    Hum Immunol; 2004 Feb; 65(2):142-56. PubMed ID: 14969769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PD-1:PD-L inhibitory pathway affects both CD4(+) and CD8(+) T cells and is overcome by IL-2.
    Carter L; Fouser LA; Jussif J; Fitz L; Deng B; Wood CR; Collins M; Honjo T; Freeman GJ; Carreno BM
    Eur J Immunol; 2002 Mar; 32(3):634-43. PubMed ID: 11857337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.